Green Thumb Industries (GTBIF) Enterprise Value (2018 - 2026)
Green Thumb Industries (GTBIF) posted Enterprise Value of -$340.5 million for Q1 2026, down 26.53% on a QoQ basis from -$269.1 million in Q4 2025, and down 61.06% year-over-year from -$874.3 million in Q1 2025.
Green Thumb Industries (GTBIF) Enterprise Value (2018 - 2026) Analysis & Trends
Green Thumb Industries' Enterprise Value history runs 9 years deep, the most recent figure standing at -$340.5 million for Q1 2026.
- Quarterly Enterprise Value fell 61.06% year-over-year to -$340.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$340.5 million (down 61.06% YoY) and the FY2025 annual result came in at -$269.1 million, down 56.55% from the prior year.
- Enterprise Value was -$340.5 million for Q1 2026 at Green Thumb Industries, down from -$269.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$136.3 million in Q3 2023 and bottomed at -$340.5 million in Q1 2026.
- A 5-year average of -$191.3 million and a median of -$174.4 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 59.18% — and 2026, when it sank 61.06%.
- Green Thumb Industries' Enterprise Value stood at -$177.2 million in 2022, then rose by 8.98% to -$161.3 million in 2023, then fell by 6.59% to -$171.9 million in 2024, then slumped by 56.55% to -$269.1 million in 2025, then retreated by 26.53% to -$340.5 million in 2026.
- Business Quant data shows GTBIF's Enterprise Value at -$340.5 million in Q1 2026, -$269.1 million in Q4 2025, and -$219.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | -340.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -340.47 Mn |
| Dec 31, 2025 | -269.09 Mn |
| Sep 30, 2025 | -219.69 Mn |
| Jun 30, 2025 | -170.72 Mn |
| Mar 31, 2025 | -211.40 Mn |
| Dec 31, 2024 | -171.88 Mn |
| Sep 30, 2024 | -173.75 Mn |
| Jun 30, 2024 | -196.05 Mn |
| Mar 31, 2024 | -223.81 Mn |
| Dec 31, 2023 | -161.26 Mn |
| Sep 30, 2023 | -136.28 Mn |
| Jun 30, 2023 | -148.49 Mn |
| Mar 31, 2023 | -185.01 Mn |
| Dec 31, 2022 | -177.17 Mn |
| Sep 30, 2022 | -146.98 Mn |
| Jun 30, 2022 | -144.96 Mn |
| Mar 31, 2022 | -174.39 Mn |
| Dec 31, 2021 | -232.06 Mn |
| Sep 30, 2021 | -285.90 Mn |
| Jun 30, 2021 | -355.14 Mn |